The Project

MSFrontier is building an independent research effort on top of the open data on this site. It will start with progressive MS, where treatment has advanced least, and ask what the trials already run can teach the ones that come next.

We are still deciding its shape: which questions come first, how the work will be checked, and who we will work with. When the plans are settled we will publish them here in full, before any analysis begins, so that anyone can see what we set out to do and judge the results against it.

If you are a researcher, a clinician or a person living with MS and would like to hear when the Project starts, or to take part, we would be glad to hear from you.